Delivery Order SPE2DB22D3004-SPE2DB25FPK84
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,394.91, is for the delivery of XTAMPZA ER 18 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of April 2, 2025 and is a Firm Fixed Price Delivery Order. This award is not associated with any set-aside requirements. AmerisourceBergen Drug Corp is the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.84 firm-fixed-price delivery order is for the supply of XTAMPZA ER 9 MG CAPSULE 100S, a specialty pharmaceutical product. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.62, is a Delivery Order for the supply of XTAMPZA ER 27 MG CAPSULE 100S. The contract has an ultimate completion date of February 28, 2025 and is a Firm Fixed Price arrangement. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,787.26, is for the delivery of XTAMPZA ER CAPS 36MG, a pharmaceutical product. The contract has a completion date of November 21, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,837.82 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the supply of XTAMPZA ER 36 MG CAPSULE 100S, a type of medication. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation, provides for the delivery of XTAMPZA ER 27 MG CAPSULE 100S to the Defense Logistics Agency (DLA) Troop Support Medical program, a component of the U.S. Department of Defense. The contract, a firm fixed price delivery order valued at $1,030.78, has an ultimate completion date of April 2, 2024. This order is issued under an indefinite delivery contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.43 firm fixed-price delivery order contract covers the supply of XTAMPZA ER 27 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,863.30 firm fixed-price delivery order is for the supply of XTAMPZA ER 36 MG capsules. The contract has an ultimate completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,706.55 firm fixed-price delivery order is for the supply of XTAMPZA ER 27 MG capsules in 100-count bottles. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.57, is for the delivery of XTAMPZA ER 9 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FPK84Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,344.17, is for the delivery of XTAMPZA ER 36 MG CAPSULE 100S, a prescription medication. The contract is a delivery order with a firm fixed price and has an ultimate completion date of February 7, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is the prime contractor, and the place of performance is Conshohocken, PA. The contract is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 2/6/25 |